|
Patients characteristics associated with hepatitis C virus (HCV) genotypes 1 and 3 infections (n = 275). |
|||
| Characteristic |
Genotype 1 (n = 163) |
Genotype 3 (n = 112) |
p value |
| n (%) |
n (%) |
||
|
|
|||
| Male |
114 (69.9) |
87 (77.7) |
0.15 |
| Age (median range, yr) |
43.0 (25–69) |
42.5 (17–67) |
0.70 |
| Risk factor for HCV infection* |
|||
| Intravenous energetic drug |
23 (14.1) |
30 (26.8) |
0.008 |
| Blood transfusion |
47 (28.8) |
24 (21.4) |
0.17 |
| Intravenous illicit drug use |
22 (13.5) |
22 (19.6) |
0.17 |
| Unknown risk |
58 (34.5) |
31(27.7) |
0.16 |
| Others** |
18 (11.0) |
11 (9.8) |
0.75 |
| ALT (median) |
62.0 |
81.5 |
0.003 |
| AST (median) |
47.0 |
65.0 |
0.001 |
| GT (median) |
61.0 |
70.0 |
0.58 |
| Positive cryoglobulin |
88 (54.0) |
80 (71.4) |
0.001 |
|
*Eleven patients had two risk factors ** Others includes intranasal use of cocaine, tattoing, body piercing, accidental needle-stick injury Reference ranges: ALT (alanine aminotransferase): 6–40 U/L; AST (aspartate aminotransferase): 6–40 U/L; 3/4GT (glutamyl transferase): 9–40 U/L | |||
Vigani et al. BMC Infectious Diseases 2008 8:164 doi:10.1186/1471-2334-8-164 |
|||